Svanberg L, Lancranjan I, Arvidsson T, Andersch B
Acta Obstet Gynecol Scand. 1987;66(1):61-2. doi: 10.3109/00016348709092956.
The clinical efficacy and safety of a single intramuscular injection of Parlodel LA, Pravidel 50 mg, were studied in the prevention of lactation in 10 postpartum women. The overall efficacy at the end of the 28 day observation period was very good in 8 postpartum women and good in 2 women and no rebound lactation occurred. The prolactin plasma levels decreased to normal levels within 4 days in 9 women. Menstrual bleeding occurred in 9 women 4 to 6 weeks after treatment. Laboratory data recorded in this study support that Pravidel is effective in suppressing postpartum lactation.
对10名产后妇女单次肌肉注射50毫克长效溴隐亭(帕罗德尔,Pravidel)预防泌乳的临床疗效和安全性进行了研究。在28天观察期结束时,8名产后妇女的总体疗效非常好,2名妇女疗效良好,且未发生泌乳反弹。9名妇女的催乳素血浆水平在4天内降至正常水平。9名妇女在治疗后4至6周出现月经出血。本研究记录的实验室数据支持帕罗德尔在抑制产后泌乳方面有效。